Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously ...

Adagene (ADAG) announced data at the SITC 39th Annual Meeting, taking place in Houston, Nov. 6 – 10, 2024. The two poster presentations ...

About Mural Oncology's IL-12 Program Native IL-12 is a highly potent pro-inflammatory cytokine, but because of its very ...

While Monday’s trading session was a win for CERo shareholders, the stock’s year-to-date (YTD) performance paints a more complex picture. As of today, CERO is down by a staggering -98.59% YTD, which ...

Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior year period. The increase in research and development expense was primarily ...

BRTX-100, a novel cell-based therapeutic engineered to target areas of the body ... ("VAS”) and at least a 30% increase in ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

He and his colleagues assessed outcomes out to 10 years in 404 patients (mean age, 45 years; 76% women; mean body mass index, 37.3) who underwent ESG ... with the Center for Advanced Therapeutic ...

The Croatian health care strike is set for Monday. Despite this, emergency and urgent medical situations will still be dealt ...

Fintel reports that on November 7, 2024, Maxim Group initiated coverage of Quince Therapeutics (NasdaqGS:QNCX) with a Buy ...

One of three patients in Cohort 5 achieved complete histological remission at 12 weeks. <li /> Consistent improve ...

The findings reveal that BNC2 neurons, when activated by leptin and possibly other signals, not only suppress appetite but also alleviate the negative feelings associated with hunger. Remarkably, ...